Radiopharmaceutical [11C] K-2 is administered once, intravenously at 370 MBq for 1 minute.

2 trials

Sponsors

Department of Physiology,Yokohama City University, School of Medicie, Yokohama City University

Conditions

Major cognitive disordersSchizophrenia

Unknown Phase

Measurement of AMPA receptor density in patients with schizophrenia: a PET study

Active, not recruitingJPRN-UMIN000039356

Department of Physiology,Yokohama City University, School of MedicieSchizophrenia

Start: 2020-01-20Target: 30Updated: 2026-06-29

A pilot study to validate the imaging value obtained from[11C]K-2 PET imaging in major cognitive disorders.

Active, not recruitingJPRN-UMIN000039885

Yokohama City UniversityMajor cognitive disorders

Start: 2020-03-27Target: 92Updated: 2026-06-29